AbbVie Stock Target Price and Analyst Consensus
| ABBV Stock | USD 164.66 0.41 0.25% |
The current analyst and expert consensus on AbbVie is Buy with 8 buy recommendations. The current projected AbbVie target price consensus is 160.21, with 29 analyst opinions. The most common way AbbVie Inc analysts use to provide public buy-or-sell recommendation is financial statements analysis. They also talk to AbbVie executives, vendors, and/or customers. AbbVie buy-or-sell recommendation module provides average expert sentiment on the projected AbbVie Inc target price to derive its highest and lowest estimates based on target price estimated volatility of 0.0. Check out Macroaxis Advice on AbbVie to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
Lowest Forecast 145.79 | Highest Forecast 177.83 | Target Price 160.21 |
AbbVie |
It's important to approach AbbVie's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
AbbVie Target Price Consensus
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. AbbVie target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. AbbVie's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 29 | Buy |
Most AbbVie analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand AbbVie stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of AbbVie Inc, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationAbbVie Target Price Projection
AbbVie's current and average target prices are 164.66 and 160.21, respectively. The current price of AbbVie is the price at which AbbVie Inc is currently trading. On the other hand, AbbVie's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On AbbVie Target Price
AbbVie Analyst Ratings
AbbVie's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about AbbVie stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of AbbVie's financials, market performance, and future outlook by experienced professionals. AbbVie's historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize AbbVie price targets
AbbVie's stock target price is an estimate of its future price, usually made by analysts. Using AbbVie's target price to determine if it is a suitable investment can be done through the following steps:- Look at AbbVie's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if AbbVie's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional AbbVie Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of AbbVie is a key component of AbbVie valuation and have some predictive power on the future returns of a AbbVie.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of AbbVie's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Momentum Invested over 70 shares | |
 | Manufacturing Invested over 40 shares | |
Check out Macroaxis Advice on AbbVie to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. Note that the AbbVie Inc information on this page should be used as a complementary analysis to other AbbVie's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Complementary Tools for AbbVie Stock analysis
When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
The data published in AbbVie's official financial statements usually reflect AbbVie's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of AbbVie Inc. For example, before you start analyzing numbers published by AbbVie accountants, it's critical to develop an understanding of what AbbVie's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of AbbVie's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, AbbVie's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in AbbVie's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of AbbVie Inc. Please utilize our Beneish M Score to check the likelihood of AbbVie's management manipulating its earnings.